SAPROPTERINE TEVA 100 mg, tablet for oral solution 120 tablets
Active ingredients: Sapropterin dihydrochloride, Sapropterin
Commercialized according to BDPMDispensing in France: Prescription only
Tablet for oral solution120 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SAPROPTERINE TEVA 100 mg, comprimé pour solution buvable
- Pharmaceutical form
- comprimé pour solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 120 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Jul 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61129650CIP73024989CIP133400930249895Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SAPROPTÉRINEcomprimé | 77 mg · un comprimé | FT |
| DICHLORHYDRATE DE SAPROPTÉRINEcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.